Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic Transplantation
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most widely applied forms of adoptive immunotherapy for the treatment of hematological malignancies. Detrimental graft-versus-host disease (GVHD), but also beneficial graft-versus-leukemia (GVL) effects occurring after allo...
Main Authors: | Mahinbanu Mammadli, Rebecca Harris, Sara Mahmudlu, Anjali Verma, Adriana May, Rohan Dhawan, Adam T. Waickman, Jyoti Misra Sen, Avery August, Mobin Karimi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3798 |
Similar Items
-
T-Cell Metabolism in Graft Versus Host Disease
by: Franziska Karl, et al.
Published: (2021-10-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
by: Martin eSzyska, et al.
Published: (2016-03-01) -
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
by: David Bastian, et al.
Published: (2019-05-01) -
TCF-1 Is Required for CD4 T Cell Persistence Functions during AlloImmunity
by: Mahinbanu Mammadli, et al.
Published: (2023-02-01) -
Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
by: Marie Czech, et al.
Published: (2022-06-01)